SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-010218
Filing Date
2023-02-16
Accepted
2023-02-16 17:52:04
Documents
2
Period of Report
2023-02-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1628
2 POA DOCUMENT poa.txt EX-24 3729
  Complete submission text file 0001209191-23-010218.txt   6901
Mailing Address 400 FAIRVIEW AVENUE NORTH, SUITE 900 SEATTLE WA 98109
Business Address 400 FAIRVIEW AVENUE NORTH, SUITE 900 SEATTLE WA 98109 206-485-7051
CHINOOK THERAPEUTICS, INC. (Issuer) CIK: 0001435049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005
Business Address
Oxtoby Andrew (Reporting) CIK: 0001765473 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37345 | Film No.: 23639628